Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
IGC Pharma, Inc. (IGC), most recent 12 months reported: revenue $1.12M, net loss $7.88M, free cash flow -$5.93M. Latest balance sheet on file: liquid cash $354K, total debt $1.08M, net cash -$728K. From SEC filings. Others in Pharmaceutical Preparations: Dare Bioscience, Inc. · LONGEVERON INC. · Neuphoria Therapeutics Inc. · China SXT Pharmaceuticals, Inc. · 60 DEGREES PHARMACEUTICALS, INC. · Shattuck Labs, Inc. · MEDICINOVA, INC. · BioXcel Therapeutics, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.